Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia

Table 5 Treatment costs

Treatment	Description	Price (£)	Source
FDC tablet solifenacin 6 mg + TOCAS 0.4 mg	One tablet per day	0.92*^‡	BNF [26]
Tolterodine 4 mg + tamsulosin 0.4 mg	One tablet + one capsule per day	1.10 (=0.92 + 0.18)^‡	BNF [26]
GP visit	Per clinic consultation lasting 17.2 minutes, excl. direct care costs, incl. qualification costs	230.0	PSSRU [41]
Surgery	Prostate transurethral resection procedure 80% without CC, 20% with major CC	2,643.4^§	NHS [42]; Antoñanzas et al. [43]

*Price parity with solifenacin 5 mg (£0.92/day); Prescription charge excluded from UK analysis. ^‡Price per day. ^§Price calculated according to Antoñanzas et al. [43]: 20% of LB25F plus 80% of LB25D.
CC, complications and comorbidities; FDC, fixed-dose combination; GP, general practitioner; TOCAS, oral controlled absorption system (OCAS™) formulation of tamsulosin.

ISSN: 1471-2490